Finance Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Beam Therapeutics · 17 hours ago

Finance Intern

Beam Therapeutics is a biotechnology company committed to establishing a leading platform for precision genetic medicines. They are seeking a highly motivated Finance Intern to partner across Finance and Procurement, gaining exposure to financial operations, sourcing, and finance systems.

BiotechnologyGeneticsMedicalTherapeutics
check
Comp. & Benefits

Responsibilities

Support the Procurement team with day-to-day analytical and operational tasks, ensuring accurate and timely deliverables
Participate in Coupa analytics and spend reporting to support sourcing and cost management activities
Assist with various SAP implementation tasks
Support standard cost and Purchase Price Variance (PPV) analysis for North Carolina operations through data collection and validation
Coordinate the gathering and organization of supplier business continuity information for Commercial procurement needs
Participate in defined procurement projects and ad hoc assignments, including data analysis, documentation, and preparation of summary materials
Assist with monthly financial close
Special projects as required

Qualification

AccountingFinanceMicrosoft OfficeData analysisCommunication skills

Required

Currently pursuing an Accounting, Finance, or Business major, with a minimum of junior standing
Proficient in Microsoft Office applications
Detail-oriented with strong organizational skills
Excellent verbal and written communication skills
Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the internship to be eligible

Company

Beam Therapeutics

twittertwittertwitter
company-logo
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Funding

Current Stage
Public Company
Total Funding
$1.19B
2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M

Leadership Team

leader-logo
John Evans
CEO
linkedin
leader-logo
Christine Bellon
Chief Legal Officer
linkedin
Company data provided by crunchbase